​
​

Viracta Therapeutics (VIRX) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChart

Viracta Therapeutics Revenue Highlights

00

Viracta Therapeutics Revenue by Period

Viracta Therapeutics Revenue by Year

DateRevenueChange
2023-12-31-100.00%
2022-12-31-100.00%
2021-12-31--100.00%
2020-12-31--94.21%
2019-12-31-774.68%
2018-12-31--64.57%
2017-12-31--73.62%
2016-12-31--17.15%
2015-12-31--46.62%
2014-12-31--27.93%
2013-12-31-111.93%
2012-12-31--24.92%
2011-12-31-15013.50%
2010-12-31--99.12%
2009-12-31--30.56%
2008-12-31--43.94%
2007-12-31--29.51%
2006-12-31--17.02%
2005-12-31--

Viracta Therapeutics generated - in revenue during NA 2023, up 100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Viracta Therapeutics Revenue by Quarter

DateRevenueChange
2024-06-30-100.00%
2024-03-31--100.00%
2023-12-31-100.00%
2023-09-30-100.00%
2023-06-30-100.00%
2023-03-31-100.00%
2022-12-31-100.00%
2022-09-30-100.00%
2022-06-30-100.00%
2022-03-31-100.00%
2021-12-31-100.00%
2021-09-30-100.00%
2021-06-30-100.00%
2021-03-31-100.00%
2020-12-31-100.00%
2020-09-30-100.00%
2020-06-30--100.00%
2020-03-31--94.21%
2019-12-31-100.00%
2019-09-30-100.00%
2019-06-30-100.00%
2019-03-31-100.00%
2018-12-31-100.00%
2018-09-30-100.00%
2018-06-30--100.00%
2018-03-31-100.00%
2017-12-31-100.00%
2017-09-30-100.00%
2017-06-30--100.00%
2017-03-31--1.04%
2016-12-31-10.82%
2016-09-30--
2016-06-30--4.69%
2016-03-31--4.48%
2015-12-31--1.90%
2015-09-30--20.02%
2015-06-30--
2015-03-31--4.69%
2014-12-31-4.92%
2014-09-30--57.06%
2014-06-30--0.30%
2014-03-31-0.30%
2013-12-31--
2013-09-30--
2013-06-30--
2013-03-31--
2012-12-31-650.57%
2012-09-30--82.33%
2012-06-30-100.00%
2012-03-31-100.00%
2011-12-31--100.00%
2011-09-30-100.00%
2011-06-30--100.00%
2011-03-31-66566.67%
2010-12-31-100.00%
2010-09-30--100.00%
2010-06-30-16.66%
2010-03-31--
2009-12-31--
2009-09-30--99.64%
2009-06-30-1467.75%
2009-03-31-1692.38%
2008-12-31--97.55%
2008-09-30--80.30%
2008-06-30-12.51%
2008-03-31-12.53%
2007-12-31-11.83%
2007-09-30--

Viracta Therapeutics generated - in revenue during Q2 2024, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

Viracta Therapeutics Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
EYPTEyePoint Pharmaceuticals--
BCYCBicycle Therapeutics--
SQZSQZ Bio--
MREOMereo BioPharma Group--
STOKStoke Therapeutics--
IGMSIGM Biosciences--
LYRALyra Therapeutics--
ALXOALX Oncology--
XFORX4 Pharmaceuticals--
CABACabaletta Bio--
RLYBRallybio--
TARAProtara Therapeutics--
INZYInozyme Pharma--
LPTXLeap Therapeutics--
VIRXViracta Therapeutics--
BMEABiomea Fusion--
TRVITrevi Therapeutics--
TERNTerns Pharmaceuticals--
VINCVincerx Pharma--
GLUEMonte Rosa Therapeutics--
TNYATenaya Therapeutics--

VIRX Revenue FAQ

What is Viracta Therapeutics’s yearly revenue?

Viracta Therapeutics's yearly revenue for 2023 was $0, representing an increase of 100.00% compared to 2022. The company's yearly revenue for 2022 was $0, representing an increase of 100.00% compared to 2021. VIRX's yearly revenue for 2021 was $0, representing a decrease of -100.00% compared to 2020.

What is Viracta Therapeutics’s quarterly revenue?

Viracta Therapeutics's quarterly revenue for Q2 2024 was $0, a 100.00% increase from the previous quarter (Q1 2024), and a 0% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $0, a -100.00% decrease from the previous quarter (Q4 2023), and a 0% increase year-over-year (Q1 2023). VIRX's quarterly revenue for Q4 2023 was $738K, a 100.00% increase from the previous quarter (Q3 2023), and a 0% increase year-over-year (Q4 2022).

What is Viracta Therapeutics’s revenue growth rate?

Viracta Therapeutics's revenue growth rate for the last 3 years (2021-2023) was 0%, and for the last 5 years (2019-2023) was -100.00%.